Top

Osteoporosis International

Published in:

01-12-2020 | Osteoporosis | Original Article

An analysis of osteoporosis in patients with hereditary multiple exostoses

Authors: K. Matsumoto, H. Ogawa, S. Nozawa, H. Akiyama

Published in: Osteoporosis International | Issue 12/2020

Abstract

Summary

We analyzed osteoporosis in 20 HME patients. According to the T-score of BMD, 30% and 67.5% of the patients fell in the range of osteopenia in the lumbar spine and femoral neck. Our results indicate HME patients have low bone mass. They do not have abnormal bone metabolism.

Introduction

There are few reports of osteoporosis in hereditary multiple exostoses (HME) patients. Therefore, the purpose of this study was to analyze osteoporosis in HME patients.

Methods

This retrospective cohort study included 20 patients diagnosed with HME. Patients underwent bone mineral density (BMD) measurement of the lumbar spine (n = 20) and femoral neck (n = 40). Bone metabolic parameters, including serum osteocalcin and urinary cross-linked N-telopeptide of type 1 collagen (NTx), were analyzed in all subjects. EXT1 and EXT2 genes were sequenced using genomic DNA. We also examined the correlation between genotype and BMD Z-score and T-score.

Results

The mean BMD values of the lumbar spine were 1.085 ± 0.116 g/cm² (n = 11) in male and 1.108 ± 0.088 g/cm² (n = 9) in female. The mean BMD values of the femoral neck area were 0.759 ± 0.125 g/cm² (n = 22) in male and 0.749 ± 0.115 g/cm² (n = 18) in female. Z-score of most HME patients show < 0, indicating that these patients tend to have low bone mass compared with the age-matched population. According to the T-score of BMD, 30% (6 of 20) and 67.5% (27 of 40) of the patients fell in the range of osteopenia in the lumbar spine and femoral neck areas, respectively. Serum osteocalcin and urinary NTx were in the normal range in most patients. There was no significant correlation between genotypes and Z-score.

Conclusion

HME patients have low bone mass, especially in the femoral neck area. They do not have abnormal bone metabolism, and there was no correlation between genotypes and Z-score.

Available only for authorised users

Akita S, Murase T, Yonenobu K, Shimada K, Masada K, Yoshikawa H (2007) Long-term results of surgery for forearm deformities in patients with multiple cartilaginous exostoses. J Bone Joint Surg Am 89(9):1993–1999PubMedCrossRef

Matsumoto Y, Matsumoto K, Harimaya K, Okada S, Doi T, Iwamoto Y (2015) Scoliosis in patients with multiple hereditary exostoses. Eur Spine J 24(7):1568–1573PubMedCrossRef

Matsumoto K, Irie F, Mackem S, Yamaguchi Y (2010) A mouse model of chondrocyte-specific somatic mutation reveals a role for Ext1 loss of heterozygosity in multiple hereditary exostoses. Proc Natl Acad Sci U S A 107(24):10932–10937PubMedPubMedCentralCrossRef

Ahn J, Ludecke HJ, Lindow S, Horton WA, Lee B, Wagner MJ, Horsthemke B, Wells DE (1995) Cloning of the putative tumour suppressor gene for hereditary multiple exostoses (EXT1). Nat Genet 11(2):137–143PubMedCrossRef

Stickens D, Clines G, Burbee D, Ramos P, Thomas S, Hogue D, Hecht JT, Lovett M, Evans GA (1996) The EXT2 multiple exostoses gene defines a family of putative tumour suppressor genes. Nat Genet 14(1):25–32PubMedCrossRef

Ludecke HJ, Ahn J, Lin X, Hill A, Wagner MJ, Schomburg L, Horsthemke B, Wells DE (1997) Genomic organization and promoter structure of the human EXT1 gene. Genomics. 40(2):351–354PubMedCrossRef

Clines GA, Ashley JA, Shah S, Lovett M (1997) The structure of the human multiple exostoses 2 gene and characterization of homologs in mouse and Caenorhabditis elegans. Genome Res 7(4):359–367PubMedPubMedCentralCrossRef

Sarrion P, Sangorrin A, Urreizti R, Delgado A, Artuch R, Martorell L, Armstrong J, Anton J, Torner F, Vilaseca MA, Nevado J, Lapunzina P, Asteggiano CG, Balcells S, Grinberg D (2013) Mutations in the EXT1 and EXT2 genes in Spanish patients with multiple osteochondromas. Sci Rep 3:1346PubMedPubMedCentralCrossRef

Jamsheer A, Socha M, Sowinska-Seidler A, Telega K, Trzeciak T, Latos-Bielenska A (2014) Mutational screening of EXT1 and EXT2 genes in Polish patients with hereditary multiple exostoses. J Appl Genet 55(2):183–188PubMedPubMedCentralCrossRef

10.

Seki H, Kubota T, Ikegawa S, Haga N, Fujioka F, Ohzeki S, Wakui K, Yoshikawa H, Takaoka K, Fukushima Y (2001) Mutation frequencies of EXT1 and EXT2 in 43 Japanese families with hereditary multiple exostoses. Am J Med Genet 99(1):59–62PubMedCrossRef

11.

Xu L, Xia J, Jiang H, Zhou J, Li H, Wang D, Pan Q, Long Z, Fan C, Deng HX (1999) Mutation analysis of hereditary multiple exostoses in the Chinese. Hum Genet 105(1–2):45–50PubMedCrossRef

12.

Ishimaru D, Gotoh M, Takayama S, Kosaki R, Matsumoto Y, Narimatsu H, Sato T, Kimata K, Akiyama H, Shimizu K, Matsumoto K (2016) Large-scale mutational analysis in the EXT1 and EXT2 genes for Japanese patients with multiple osteochondromas. BMC Genet 17:52PubMedPubMedCentralCrossRef

13.

Schmale GA, Conrad EU 3rd, Raskind WH (1994) The natural history of hereditary multiple exostoses. J Bone Joint Surg Am 76(7):986–992PubMedCrossRef

14.

Bovee JV (2008) Multiple osteochondromas. Orphanet J Rare Dis 3:3PubMedPubMedCentralCrossRef

15.

Czajka CM, DiCaprio MR (2015) What is the proportion of patients with multiple hereditary exostoses who undergo malignant degeneration? Clin Orthop Relat Res 473(7):2355–2361PubMedPubMedCentralCrossRef

16.

Goud AL, de Lange J, Scholtes VA, Bulstra SK, Ham SJ (2012) Pain, physical and social functioning, and quality of life in individuals with multiple hereditary exostoses in The Netherlands: a national cohort study. J Bone Joint Surg Am 94(11):1013–1020PubMedCrossRef

17.

Legeai-Mallet L, Munnich A, Maroteaux P, Le Merrer M (1997) Incomplete penetrance and expressivity skewing in hereditary multiple exostoses. Clin Genet 52(1):12–16PubMedCrossRef

18.

Pedrini E, Jennes I, Tremosini M, Milanesi A, Mordenti M, Parra A, Sgariglia F, Zuntini M, Campanacci L, Fabbri N, Pignotti E, Wuyts W, Sangiorgi L (2011) Genotype-phenotype correlation study in 529 patients with multiple hereditary exostoses: identification of “protective” and “risk” factors. J Bone Joint Surg Am 93(24):2294–2302PubMedCrossRef

19.

Lemos MC, Kotanko P, Christie PT, Harding B, Javor T, Smith C, Eastell R, Thakker RV (2005) A novel EXT1 splice site mutation in a kindred with hereditary multiple exostosis and osteoporosis. J Clin Endocrinol Metab 90(9):5386–5392PubMedCrossRef

20.

Nozawa S, Inubushi T, Irie F, Takigami I, Matsumoto K, Shimizu K, Akiyama H, Yamaguchi Y (2018) Osteoblastic heparan sulfate regulates osteoprotegerin function and bone mass. JCI Insight. 8;3(3)

21.

Orimo H, Hayashi Y, Fukunaga M, Sone T, Fujiwara S, Shiraki M, Kushida K, Miyamoto S, Soen S, Nishimura J, Oh-Hashi Y, Hosoi T, Gorai I, Tanaka H, Igai T, Kishimoto H (2001) Osteoporosis Diagnostic Criteria Review Committee, Japanese Society for Bone and Mineral Research. Diagnostic criteria for primary osteoporosis: year 2000 revision. J Bone Miner Metab 19(6):331–337PubMedCrossRef

22.

Prevention and management of osteoporosis. (2003) World Health Organ Tech Rep Ser. 921:1–164

23.

Lin X, Wei G, Shi Z, Dryer L, Esko JD, Wells DE, Matzuk MM (2000) Disruption of gastrulation and heparan sulfate biosynthesis in EXT1-deficient mice. Dev Biol 224(2):299–311PubMedCrossRef

24.

Charoenngam N, Shirvani A, Holick MF (2019) Vitamin D for skeletal and non-skeletal health: what we should know. J Clin Orthop Trauma 10(6):1082–1093PubMedPubMedCentralCrossRef

25.

Kraushaar DC, Rai S, Condac E, Nairn A, Zhang S, Yamaguchi Y, Moremen K, Dalton S, Wang L (2012) Heparan sulfate facilitates FGF and BMP signaling to drive mesoderm differentiation of mouse embryonic stem cells. J Biol Chem 287(27):22691–22700PubMedPubMedCentralCrossRef

26.

Signori E, Massi E, Matera MG, Poscente M, Gravina C, Falcone G, Rosa MA, Rinaldi M, Wuyts W, Seripa D, Dallapiccola B, Fazio VM (2007) A combined analytical approach reveals novel EXT1/2 gene mutations in a large cohort of Italian multiple osteochondromas patients. Genes Chromosom Cancer 46(5):470–477PubMedCrossRef

27.

Jennes I, Entius MM, Van Hul E, Parra A, Sangiorgi L, Wuyts W (2008) Mutation screening of EXT1 and EXT2 by denaturing high-performance liquid chromatography, direct sequencing analysis, fluorescence in situ hybridization, and a new multiplex ligation-dependent probe amplification probe set in patients with multiple osteochondromas. J Mol Diagn 10(1):85–92PubMedPubMedCentralCrossRef

28.

Alvarez C, Tredwell S, De Vera M, Hayden M (2006) The genotype-phenotype correlation of hereditary multiple exostoses. Clin Genet 70(2):122–130PubMedCrossRef

29.

Li Y, Wang J, Wang Z, Tang J, Yu T (2017) A genotype-phenotype study of hereditary multiple exostoses in forty-six Chinese patients. BMC Med Genet 18(1):126PubMedPubMedCentralCrossRef

30.

Le Merrer M, Legeai-Mallet L, Jeannin PM, Horsthemke B, Schinzel A, Plauchu H, Toutain A, Achard F, Munnich A, Maroteaux P (1994) A gene for hereditary multiple exostoses maps to chromosome 19p. Hum Mol Genet 3(5):717–722PubMedCrossRef

Title: An analysis of osteoporosis in patients with hereditary multiple exostoses
Authors: K. Matsumoto
H. Ogawa
S. Nozawa
H. Akiyama
Publication date: 01-12-2020
Publisher: Springer London
Keywords: Osteoporosis
Osteoporosis
Published in: Osteoporosis International / Issue 12/2020
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-020-05533-7

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

An analysis of osteoporosis in patients with hereditary multiple exostoses

Abstract

Summary

Introduction

Methods

Results

Conclusion

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Summary

Introduction

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 12/2020

Hypercalcemia upon denosumab withdrawal in primary hyperparathyroidism: a case report and literature review

A comparison of floor surfaces for injury prevention in care settings: impact forces and horizontal pulling force required to move wheeled equipment

Frequency of normal bone measurement in postmenopausal women with fracture: a registry-based cohort study

Vertebral fracture assessment (VFA) for osteoporosis screening in US postmenopausal women: is it cost-effective?

Blindness increases the risk for hip fracture and vertebral fracture but not the risk for distal radius fracture: a longitudinal follow-up study using a national sample cohort

Risk factors and renal outcomes of low bone mineral density in patients with non-dialysis chronic kidney disease